Cardiotoxicity among Patients Using Pertuzumab, Trastuzumab and Taxane with HER2-Positive Early-Stage Breast Cancer: A Single-Centre Experience
Alanood S. Algarni, Anan A. Alfi, Azuf T. Turkistani, Layal E. Malki, Nouf F. Alghanam, Shayma S. Abdulghani, Majed Ramadan & Meteb Al-Foheidi · Journal of Pharmaceutical Research International · 2021
Aim: In this study, we aimed to investigate the incidence rate, risk factors, and mortality rates in patients with early-stage breast cancer using anti-HER2 (Human epidermal growth factor receptor-2) treatment. Patients and Methods: A total of 106 patients diagnosed with human ep...
Open access
Research Article
10.9734/jpri/2021/v33i59B34405